Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
出版年份 2018 全文链接
标题
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
作者
关键词
Diffuse large B cell lymphoma, Central nervous system prophylaxis, Extranodal lymphoma, MYD88, Cell of origin, Radiation therapy
出版物
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 19, Issue 8, Pages -
出版商
Springer Nature
发表日期
2018-06-21
DOI
10.1007/s11864-018-0555-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- High prevalence ofMYD88andCD79Bmutations in intravascular large B-cell lymphoma
- (2018) Anne M. R. Schrader et al. BLOOD
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy
- (2017) Tarec Christoffer El-Galaly et al. EUROPEAN JOURNAL OF CANCER
- Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH
- (2017) Beenu Thakral et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features
- (2017) Yang Liu et al. HUMAN PATHOLOGY
- Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
- (2017) Annette M. Staiger et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type
- (2017) Anne Pham-Ledard et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Primary Breast Lymphoma in the United States: 1975–2013
- (2017) Alexandra Thomas et al. JNCI-Journal of the National Cancer Institute
- Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
- (2017) K Karube et al. LEUKEMIA
- Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL
- (2017) Mareike Frick et al. LEUKEMIA & LYMPHOMA
- Primary Breast Lymphoma in the United States: 1975–2013
- (2017) Alexandra Thomas et al. JNCI-Journal of the National Cancer Institute
- Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management
- (2016) Ryan A. Wilcox AMERICAN JOURNAL OF HEMATOLOGY
- De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort
- (2016) Lapo Alinari et al. AMERICAN JOURNAL OF HEMATOLOGY
- Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma
- (2016) Kohei Taniguchi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
- (2016) K. J. Savage et al. BLOOD
- Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era
- (2016) Robert Kridel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement
- (2016) Tarec Christoffer El-Galaly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model
- (2016) Roopesh Kansara et al. BRITISH JOURNAL OF HAEMATOLOGY
- Central nervous system prophylaxis in diffuse large B-cell lymphoma
- (2016) Mohammad Faizan Zahid et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Lymphoma of the liver: Clinicopathological features of 19 patients
- (2016) Yue Peng et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)
- (2016) Francisco-Javier Peñalver et al. HAEMATOLOGICA
- CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2016) Norbert Schmitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies
- (2016) Sylvain Pilorge et al. LEUKEMIA & LYMPHOMA
- Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era
- (2016) Nicola Lehners et al. LEUKEMIA & LYMPHOMA
- P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
- (2016) Xuan J Wang et al. MODERN PATHOLOGY
- Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P
- (2016) Keina Nagakita et al. PATHOLOGY INTERNATIONAL
- Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
- (2016) A Kawajiri et al. Blood Cancer Journal
- Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)
- (2016) Francisco-Javier Peñalver et al. HAEMATOLOGICA
- Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma
- (2015) Tarec Christoffer El-Galaly et al. AMERICAN JOURNAL OF HEMATOLOGY
- Targetable genetic features of primary testicular and primary central nervous system lymphomas
- (2015) B. Chapuy et al. BLOOD
- Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base
- (2015) Adam J. Olszewski et al. CANCER CAUSES & CONTROL
- Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas
- (2015) E. Braggio et al. CLINICAL CANCER RESEARCH
- Update in primary pulmonary lymphomas
- (2015) Jose Cardenas-Garcia et al. CURRENT OPINION IN PULMONARY MEDICINE
- Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study
- (2015) Siria A. Lemma et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Benefit of Consolidative Radiation Therapy for Primary Bone Diffuse Large B-Cell Lymphoma
- (2015) Randa Tao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Oncogenic Mutations and Chromosomal Aberrations in Primary Extranodal Diffuse Large B-Cell Lymphomas of the Thyroid—A Study of 21 Cases
- (2015) Juliana Knief et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium
- (2015) L Deng et al. LEUKEMIA
- Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era
- (2015) Chieh-Sheng Lu et al. LEUKEMIA & LYMPHOMA
- High prevalence of theMYD88mutation in testicular lymphoma: Immunohistochemical and genetic analyses
- (2015) Naoki Oishi et al. PATHOLOGY INTERNATIONAL
- Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse
- (2014) Xin-xin Cao et al. ANNALS OF HEMATOLOGY
- The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas
- (2014) N. Murawski et al. BLOOD
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
- (2014) A. M. Petrich et al. BLOOD
- Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)
- (2014) Carlo Messina et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic significance of soft tissue extension, International Prognostic Index, and multifocality in primary bone lymphoma: a single institutional experience
- (2014) Huanwen Wu et al. BRITISH JOURNAL OF HAEMATOLOGY
- A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era
- (2014) Peter J. Hosein et al. BRITISH JOURNAL OF HAEMATOLOGY
- Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2014) Andrés J. M. Ferreri et al. BRITISH JOURNAL OF HAEMATOLOGY
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience
- (2014) Yasuhiro Oki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Risk of CNS dissemination in extranodal lymphomas
- (2014) Andrés J M Ferreri LANCET ONCOLOGY
- Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma
- (2014) Gyeong-Won Lee et al. LEUKEMIA & LYMPHOMA
- Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma
- (2014) Adam J. Olszewski et al. LEUKEMIA RESEARCH
- Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study)
- (2014) M. Bruno Ventre et al. ONCOLOGIST
- Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
- (2014) S-H Kuo et al. Blood Cancer Journal
- Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France
- (2014) Florent Grange et al. JAMA Dermatology
- High Frequency and Clinical Prognostic Value of MYD88 L265P Mutation in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type
- (2014) Anne Pham-Ledard et al. JAMA Dermatology
- Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database
- (2013) Jorge J. Castillo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Primary adrenal lymphoma: a systematic review
- (2013) Armin Rashidi et al. ANNALS OF HEMATOLOGY
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
- (2013) H. Horn et al. BLOOD
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- Primary Thyroid Lymphoma: A Clinical Review
- (2013) Stephanie Aleskow Stein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement
- (2013) Gerhard Held et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
- (2013) David Cunningham et al. LANCET
- High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
- (2013) W Kraan et al. LEUKEMIA
- Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
- (2013) Jing Zhang et al. LEUKEMIA & LYMPHOMA
- Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma
- (2013) Anne Pham-Ledard et al. MODERN PATHOLOGY
- Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
- (2013) Kieron Dunleavy et al. NEW ENGLAND JOURNAL OF MEDICINE
- The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma
- (2012) Byeong Seok Sohn et al. ANNALS OF HEMATOLOGY
- Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study
- (2012) L. de Leval et al. ANNALS OF ONCOLOGY
- Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
- (2012) H. Holte et al. ANNALS OF ONCOLOGY
- Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas
- (2012) S.-H. Kuo et al. BLOOD
- Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial
- (2012) A. J. M. Ferreri et al. BLOOD
- Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) Z. Y. Xu-Monette et al. BLOOD
- Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
- (2012) A. Gonzalez-Aguilar et al. CLINICAL CANCER RESEARCH
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
- (2012) Yu Kim et al. Journal of Hematology & Oncology
- The Role of Genotype in 104 Cases of Diffuse Large B-Cell Lymphoma Primary of Breast
- (2011) Agustin Aviles et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab
- (2011) K. Miyazaki et al. ANNALS OF ONCOLOGY
- The molecular pathogenesis of primary mediastinal large B-cell lymphoma
- (2011) C. Steidl et al. BLOOD
- Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24 553 patients with Hashimoto’s disease
- (2011) Natsuko Watanabe et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era
- (2011) Hiroyuki Takahashi et al. CANCER
- Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era
- (2011) Anita Kumar et al. CANCER
- Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse
- (2011) D. Villa et al. HAEMATOLOGICA
- Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy
- (2011) Ho-Young Yhim et al. INTERNATIONAL JOURNAL OF CANCER
- First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
- (2011) Umberto Vitolo et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial
- (2011) Christian Récher et al. LANCET
- Treatment results and prognostic factors in primary thyroid lymphoma patients: a Rare Cancer Network study
- (2010) C. Onal et al. ANNALS OF ONCOLOGY
- Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
- (2010) Jeremy S. Abramson et al. CANCER
- CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
- (2009) V. Boehme et al. BLOOD
- MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- (2009) K. J. Savage et al. BLOOD
- CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
- (2009) L. Fischer et al. CLINICAL CANCER RESEARCH
- Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
- (2009) N. Tomita et al. HAEMATOLOGICA
- Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations
- (2009) N Niitsu et al. LEUKEMIA
- Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516—The Southwest Oncology Group
- (2008) Steven H. Bernstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
- (2007) G. Ryan et al. ANNALS OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started